LatestCancer Drug May Work Differently Than Expected, Raising Clinical Trial Concerns
Health

C. difficile carriers without symptoms drive most infections in cancer hospital wards

C. difficile carriers without symptoms drive most infections in cancer hospital wards
Cancer
Summary

A new study modeling Clostridioides difficile transmission in hospital cancer units reveals that asymptomatic patients are the primary source of new infections, rather than symptomatic patients. Researchers found that most C. difficile introductions occur when infected but non-symptomatic patients are admitted to oncology wards. This discovery is significant because cancer patients are particularly vulnerable to serious C. difficile infections. The findings could help hospitals develop better screening and prevention protocols to protect this high-risk population from dangerous transmission events.

Medical Xpress

Originally published on

Medical Xpress

Read full article(opens in new tab)

Fetched: October 6, 2026 at 10:01 AM

Related News

More news you might be interested in

View all
Cancer Drug May Work Differently Than Expected, Raising Clinical Trial Concerns
Health
Cancer

Cancer Drug May Work Differently Than Expected, Raising Clinical Trial Concerns

A new study from the University of Sydney, in collaboration with international research institutions, reveals that a cancer drug currently in clinical trials may operate through a different mechanism than scientists originally believed. This discovery raises important questions about how the drug was initially approved to enter human testing and highlights potential gaps in pre-clinical research validation. The findings underscore the critical importance of thoroughly understanding a drug's mechanism of action before advancing to patient trials. For cancer patients and those enrolled in related clinical studies, this research emphasizes the need for continued monitoring and transparency regarding how experimental treatments actually work in the body.

3 hours ago
Medical Xpress
Can You Live Longer for $5,500? The Rise of Longevity Clinics at Hospitals
Health

Can You Live Longer for $5,500? The Rise of Longevity Clinics at Hospitals

Longevity clinics are emerging as a new trend at major nonprofit hospitals, offering personalized health advice and cutting-edge diagnostic tests to help patients extend their lifespan. These clinics promise comprehensive evaluations but come at a significant cost, ranging from $5,500 to $45,000 annually. While they target affluent patients seeking preventive care and optimization of their health span, questions remain about the scientific evidence supporting their expensive interventions. For patients in Puerto Rico considering these services, it's important to consult with your primary care physician about whether such programs offer real benefits beyond standard preventive medicine.

4 hours ago
STAT News
Opinion: Why the FDA Should Not Approve an Ineffective Multicancer Screening Test
Health
Cancer

Opinion: Why the FDA Should Not Approve an Ineffective Multicancer Screening Test

Medical expert H. Gilbert Welch argues against FDA approval of Grail's multicancer screening test, emphasizing that detecting more cancer cases does not constitute medical progress. True progress requires reducing cancer mortality rates, not simply increasing diagnoses. The test's effectiveness in actually saving lives remains questionable, raising concerns about potential overdiagnosis and unnecessary patient anxiety. Healthcare policy experts stress that screening tests must demonstrate clear benefits in reducing deaths before widespread implementation, protecting patients from harm and ensuring resources are used efficiently.

4 hours ago
STAT News
Doctor's Warning: How AI Tools Are Driving Up Healthcare Costs Despite Good Documentation
Health

Doctor's Warning: How AI Tools Are Driving Up Healthcare Costs Despite Good Documentation

A physician warns that artificial intelligence tools used in healthcare documentation, while well-intentioned, can inadvertently inflate hospital bills and increase costs for patients. Despite accurate medical records, AI systems may prompt physicians to document additional information that leads to higher billing codes and expenses. This growing concern highlights the gap between technological efficiency and actual healthcare affordability. Patients should be aware that AI-assisted documentation—though improving clinical accuracy—may not translate to lower medical bills. Understanding these unintended consequences is crucial for advocating for transparent, patient-centered healthcare pricing reform.

4 hours ago
STAT News